Research on brain cancer epidemiology detailed by scientists at Eli Lilly and Company

Investigators publish new data in the report "Utilization and cost of health care services associated with primary malignant brain tumors in the United States. To evaluate the economic burden of primary malignant brain tumors in a commercially insured population in the United States, and to identify the primary drivers of health care resource use and cost. A retrospective cohort analysis was performed using a 1998-2000 database containing inpatient, outpatient, and pharmacy claims for employees, their dependents, and early retirees of over 50 large US employers with wide geographic distribution. Patients were followed from first brain tumor diagnosis until death, termination of health...

Want to see the full article?

• Purchase this article for only $3.00